KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Net Income: 2009-2025

Historic Net Income for Ionis Pharmaceuticals (IONS) over the last 17 years, with Sep 2025 value amounting to -$128.6 million.

  • Ionis Pharmaceuticals' Net Income rose 8.45% to -$128.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$257.0 million, marking a year-over-year increase of 28.53%. This contributed to the annual value of -$454.5 million for FY2024, which is 23.84% down from last year.
  • Per Ionis Pharmaceuticals' latest filing, its Net Income stood at -$128.6 million for Q3 2025, which was down 204.09% from $123.6 million recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Net Income ranged from a high of $223.7 million in Q4 2021 and a low of -$147.4 million during Q3 2023.
  • Moreover, its 3-year median value for Net Income was -$124.3 million (2023), whereas its average is -$88.5 million.
  • Per our database at Business Quant, Ionis Pharmaceuticals' Net Income crashed by 949.60% in 2024 and then skyrocketed by 286.45% in 2025.
  • Over the past 5 years, Ionis Pharmaceuticals' Net Income (Quarterly) stood at $223.7 million in 2021, then crashed by 123.66% to -$52.9 million in 2022, then skyrocketed by 81.10% to -$10.0 million in 2023, then plummeted by 949.60% to -$105.0 million in 2024, then climbed by 8.45% to -$128.6 million in 2025.
  • Its Net Income stands at -$128.6 million for Q3 2025, versus $123.6 million for Q2 2025 and -$146.9 million for Q1 2025.